{
  "healthyPatterns": {
    "networkDensity": { 
      "min": 0.3, 
      "max": 0.7,
      "optimal": 0.45
    },
    "sectorBalance": { 
      "min": 0.15, 
      "max": 0.4,
      "description": "No single sector should dominate more than 40%"
    },
    "connectionGrowth": { 
      "min": 0.05, 
      "max": 0.15,
      "timeframe": "quarterly"
    },
    "financialHealth": {
      "min": 6.0,
      "max": 10.0,
      "description": "Average financial health score across network"
    }
  },
  "anomalyIndicators": {
    "rapidIsolation": { 
      "threshold": 0.3, 
      "timeframe": "7d",
      "description": "Company loses 30%+ connections in 7 days"
    },
    "massCorrelation": { 
      "threshold": 0.8, 
      "companies": 5,
      "description": "5+ companies showing 80%+ correlation"
    },
    "volumeSpike": { 
      "multiplier": 3, 
      "duration": "2d",
      "description": "Trading volume 3x normal for 2+ days"
    },
    "valuationDisconnect": {
      "threshold": 0.25,
      "description": "Company valued 25%+ away from network peers"
    },
    "fundingDrought": {
      "threshold": 90,
      "unit": "days",
      "description": "No sector funding for 90+ days"
    }
  },
  "seasonalPatterns": {
    "Q1": {
      "trends": ["Increased M&A activity", "Budget planning cycles"],
      "typical_activity": 1.2,
      "sectors_active": ["neurodiagnostics", "medical_devices"]
    },
    "Q2": {
      "trends": ["Partnership announcements peak", "Conference season"],
      "typical_activity": 1.4, 
      "sectors_active": ["digital_health", "therapeutics"]
    },
    "Q3": {
      "trends": ["Funding round season", "IPO preparations"],
      "typical_activity": 1.6,
      "sectors_active": ["all"]
    },
    "Q4": {
      "trends": ["Regulatory filings increase", "Year-end acquisitions"],
      "typical_activity": 1.1,
      "sectors_active": ["therapeutics", "medical_devices"]
    }
  },
  "riskFactors": {
    "regulatory": {
      "weight": 0.3,
      "indicators": ["FDA guidance changes", "Reimbursement policy shifts"],
      "sectors_affected": ["therapeutics", "medical_devices"]
    },
    "competitive": {
      "weight": 0.25, 
      "indicators": ["Big tech entry", "New technology disruption"],
      "sectors_affected": ["digital_health", "neurodiagnostics"]
    },
    "economic": {
      "weight": 0.2,
      "indicators": ["Interest rate changes", "Healthcare spending cuts"],
      "sectors_affected": ["all"]
    },
    "technical": {
      "weight": 0.15,
      "indicators": ["AI advancement", "Clinical trial failures"],
      "sectors_affected": ["neurodiagnostics", "therapeutics"]
    },
    "market": {
      "weight": 0.1,
      "indicators": ["Investor sentiment", "Public market conditions"],
      "sectors_affected": ["all"]
    }
  },
  "opportunitySignals": {
    "consolidation": {
      "indicators": ["Fragmented market share", "Overlapping capabilities"],
      "probability_multiplier": 1.5
    },
    "partnership": {
      "indicators": ["Complementary technologies", "Geographic expansion"],
      "probability_multiplier": 1.3
    },
    "acquisition": {
      "indicators": ["Financial distress", "Strategic value"],
      "probability_multiplier": 1.8
    }
  }
}